Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Alpine Immune Sciences (ALPN) Short Interest Ratio & Short Volume

Alpine Immune Sciences logo

Alpine Immune Sciences Short Interest Data

Alpine Immune Sciences (ALPN) has a short interest of 3.89 million shares. This marks a -17.93% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.7, indicating that it would take 1.7 days of the average trading volume of 1.92 million shares to cover all short positions.

Current Short Interest
3,890,000 shares
Previous Short Interest
4,740,000 shares
Change Vs. Previous Month
-17.93%
Dollar Volume Sold Short
$251.26 million
Short Interest Ratio
1.7 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
68,598,000 shares
Percentage of Shares Shorted
5.67%
Today's Trading Volume
2 shares
Average Trading Volume
1,917,072 shares
Today's Volume Vs. Average
0%
Short Selling Alpine Immune Sciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Alpine Immune Sciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ALPN Short Interest Over Time

ALPN Days to Cover Over Time

ALPN Percentage of Float Shorted Over Time

Alpine Immune Sciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20243,890,000 shares $251.26 million -17.9%N/A1.7 $64.59
4/15/20244,740,000 shares $305.35 million -10.2%N/A2.1 $64.42
3/31/20245,280,000 shares $209.30 million -5.9%N/A4.4 $39.64
3/15/20245,610,000 shares $204.09 million +26.6%N/A5.1 $36.38
2/29/20244,430,000 shares $156.02 million +9.9%N/A4.4 $35.22
2/15/20244,030,000 shares $120.42 million +20.7%N/A4.3 $29.88
1/31/20243,340,000 shares $88.88 million +38.6%N/A3.6 $26.61
1/15/20242,410,000 shares $49.28 million -39.5%N/A3.1 $20.45
12/31/20233,980,000 shares $75.86 million +32.7%N/A5 $19.06
12/15/20233,000,000 shares $56.70 million -9.6%N/A4 $18.90
11/30/20233,320,000 shares $51.46 million -23.7%N/A5.1 $15.50
11/15/20234,350,000 shares $54.94 million +51.0%N/A7.5 $12.63
10/31/20232,880,000 shares $29.49 million +31.5%N/A5.6 $10.24
10/15/20232,190,000 shares $22.47 million -21.8%N/A6.8 $10.26
9/30/20232,800,000 shares $32.06 million +6.9%N/A11 $11.45
9/15/20232,620,000 shares $32.93 million +4.0%N/A11.3 $12.57
8/31/20232,520,000 shares $31.12 million +28.6%N/A10.8 $12.35
8/15/20231,960,000 shares $26.46 million +31.5%N/A8.9 $13.50
7/31/20231,490,000 shares $18.68 million +0.7%N/A6.5 $12.54
7/15/20231,480,000 shares $16.32 million -3.3%N/A7.8 $11.03
6/30/20231,530,000 shares $15.73 million +26.5%N/A8.9 $10.28
6/15/20231,210,000 shares $13.19 million +1.7%N/A7.2 $10.90
5/31/20231,190,000 shares $11.85 million +3.5%N/A10.3 $9.96
5/15/20231,150,000 shares $9.97 million +8.5%N/A10.7 $8.67
4/30/20231,060,000 shares $7.94 million +1.9%N/A14.8 $7.49
4/15/20231,040,000 shares $7.60 million -1.0%N/A13.3 $7.31
3/31/20231,050,000 shares $8.11 million +17.6%N/A12.5 $7.72
3/15/2023892,900 shares $7.18 million +10.8%N/A9.7 $8.04
2/28/2023805,900 shares $6.42 million +8.7%N/A7.5 $7.97
2/15/2023741,100 shares $6.24 million -2.8%N/A6.7 $8.42
1/31/2023762,700 shares $6.41 million -6.6%N/A6.7 $8.40
1/15/2023816,200 shares $7.14 million -65.0%N/A6.6 $8.75
12/30/20222,330,000 shares $17.13 million -0.4%N/A19 $7.35
12/15/20222,340,000 shares $15.28 million +6.4%N/A18.4 $6.53
11/30/20222,200,000 shares $13.82 million +4.3%N/A19.4 $6.28
11/15/20222,110,000 shares $13.19 million +11.6%N/A19.4 $6.25
10/31/20221,890,000 shares $11.17 million +2.7%N/A19.5 $5.91
10/15/20221,840,000 shares $13.06 million +12.9%N/A20.2 $7.10
9/30/20221,630,000 shares $11.74 million +19.0%N/A20.7 $7.20
9/15/20221,370,000 shares $11.10 million -2.1%7.0%17.6 $8.10
How Low-Cost Stocks Generate Monthly Income (Ad)

Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!

👉 Yes, I Want the Free Report! 👈
8/31/20221,400,000 shares $10.51 million No Change10.4%20.8 $7.51
8/15/20221,400,000 shares $12.15 million +0.7%10.4%16.5 $8.68
7/31/20221,390,000 shares $11.05 million -0.7%11.4%14.7 $7.95
7/15/20221,400,000 shares $12.60 million +0.7%11.4%14.4 $9.00
6/30/20221,390,000 shares $11.83 million -6.1%11.3%12.8 $8.51
6/15/20221,480,000 shares $12.71 million +4.2%12.1%12.6 $8.59
5/31/20221,420,000 shares $13.21 million No Change11.6%13.3 $9.30
5/15/20221,420,000 shares $10.72 million -0.7%11.6%13.4 $7.55
4/30/20221,430,000 shares $13.16 million +7.5%10.2%12.1 $9.20
4/15/20221,330,000 shares $10.64 million -2.2%9.5%11.2 $8.00
3/31/20221,360,000 shares $12.20 million -2.2%9.7%11.3 $8.97
3/15/20221,390,000 shares $10.65 million +1.5%10.3%10.5 $7.66
2/28/20221,370,000 shares $11.29 million +21.2%10.2%10.4 $8.24
2/15/20221,130,000 shares $8.99 million +4.6%8.4%8.9 $7.96
1/31/20221,080,000 shares $9.18 million +1.9%8.0%10.3 $8.50
1/15/20221,060,000 shares $11.03 million +3.9%7.8%10.2 $10.41
12/31/20211,020,000 shares $14.13 million +118.0%7.5%10.9 $13.85
12/15/2021467,800 shares $5.86 million +23.9%3.5%4.8 $12.53
11/30/2021377,700 shares $4.09 million -7.2%2.8%4.3 $10.83
11/15/2021407,200 shares $5.39 million +2.0%3.0%4.4 $13.24
10/29/2021399,100 shares $5.05 million -4.4%4.4%4.9 $12.65
10/15/2021417,600 shares $4.75 million -11.9%4.6%5.1 $11.38
9/30/2021474,200 shares $5.06 million -27.6%5.2%5.3 $10.67
9/15/2021654,800 shares $6.42 million -14.7%6.4%6.2 $9.81
8/31/2021767,400 shares $7.30 million -4.4%7.6%7.2 $9.51
8/13/2021802,300 shares $7.42 million +1.9%8.1%6.7 $9.25
7/30/2021787,100 shares $6.96 million +1.7%7.9%5.8 $8.84
7/15/2021774,200 shares $6.46 million -9.0%6.0%5.6 $8.35
6/30/2021850,700 shares $7.66 million +47.0%6.5%6.3 $9.00
6/15/2021578,700 shares $5.38 million -6.2%4.5%5.4 $9.29
5/28/2021616,800 shares $6.58 million -2.2%4.8%6 $10.66
5/14/2021630,700 shares $7.24 million +0.6%6.4%5.7 $11.48
4/30/2021626,700 shares $8.05 million +4.2%4.6%5.8 $12.84
4/15/2021601,700 shares $6.78 million -6.6%4.4%5.1 $11.26
3/31/2021644,300 shares $6.55 million +17.6%3.9%5.1 $10.17
3/15/2021548,000 shares $7.30 million +42.2%4.3%3.9 $13.33
2/26/2021385,500 shares $4.40 million +2.2%3.0%2.6 $11.41
2/12/2021377,200 shares $4.91 million +20.9%3.0%2.9 $13.03
1/29/2021311,900 shares $3.68 million -1.7%2.5%2.7 $11.81
1/15/2021317,400 shares $4.41 million +502.3%2.5%3.3 $13.89
12/31/202052,700 shares $661,912.00 +86.9%0.4%0.7 $12.56
12/15/202028,200 shares $377,880.00 +4.8%0.2%0.4 $13.40
11/30/202026,900 shares $264,696.00 +5.5%0.2%0.6 $9.84
11/15/202025,500 shares $208,590.00 -22.5%0.2%0.6 $8.18
10/30/202032,900 shares $252,672.00 +29.5%0.3%0.7 $7.68
10/15/202025,400 shares $217,170.00 -5.2%0.2%0.4 $8.55
9/30/202026,800 shares $235,572.00 +230.9%0.2%0.4 $8.79
9/15/20208,100 shares $67,068.00 +14.1%0.1%0.1 $8.28
8/31/20207,100 shares $57,936.00 -62.8%0.1%0 $8.16
8/14/202019,100 shares $179,731.00 +27.3%0.2%0 $9.41
How Low-Cost Stocks Generate Monthly Income (Ad)

Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!

👉 Yes, I Want the Free Report! 👈
7/31/202015,000 shares $172,500.00 +167.9%0.2%0 $11.50
7/15/20205,600 shares $52,584.00 -87.6%0.1%0 $9.39
6/30/202045,200 shares $405,896.00 +250.4%0.5%0.1 $8.98
6/15/202012,900 shares $48,117.00 +104.8%0.2%0 $3.73
5/29/20206,300 shares $22,806.00 -27.6%0.1%0.3 $3.62
5/15/20208,700 shares $26,535.00 +58.2%0.1%0.5 $3.05
4/30/20205,500 shares $16,225.00 -33.7%0.1%0.3 $2.95
4/15/20208,300 shares $26,560.00 No Change0.1%0.5 $3.20
3/31/20208,300 shares $27,390.00 +88.6%0.1%0.4 $3.30
3/13/20204,400 shares $12,804.00 -56.0%0.1%0.3 $2.91
2/28/202010,000 shares $22,000.00 +66.7%0.1%0.6 $2.20
2/14/20206,000 shares $18,000.00 -40.6%0.1%0.3 $3.00
1/31/202010,100 shares $32,320.00 -57.4%0.1%0.6 $3.20
1/15/202023,700 shares $71,100.00 +20.9%0.3%1.1 $3.00
12/31/201919,600 shares $64,288.00 +3.2%0.2%0.8 $3.28

ALPN Short Interest - Frequently Asked Questions

What is Alpine Immune Sciences' current short interest?

Short interest is the volume of Alpine Immune Sciences shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 3,890,000 shares of ALPN short. Learn More on Alpine Immune Sciences' current short interest.

What is a good short interest ratio for Alpine Immune Sciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALPN shares currently have a short interest ratio of 2.0. Learn More on Alpine Immune Sciences's short interest ratio.

Is Alpine Immune Sciences' short interest increasing or decreasing?

Alpine Immune Sciences saw a decline in short interest in April. As of April 30th, there was short interest totaling 3,890,000 shares, a decline of 17.9% from the previous total of 4,740,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Alpine Immune Sciences' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Alpine Immune Sciences: BeiGene, Ltd. (1.36%), United Therapeutics Co. (4.75%), Viatris Inc. (1.78%), Royalty Pharma plc (4.12%), Summit Therapeutics Inc. (2.28%), Genmab A/S (0.32%), Insmed Incorporated (7.05%), BioMarin Pharmaceutical Inc. (3.02%), Dr. Reddy's Laboratories Limited (1.32%), Sarepta Therapeutics, Inc. (6.09%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Alpine Immune Sciences stock?

Short selling ALPN is an investing strategy that aims to generate trading profit from Alpine Immune Sciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Alpine Immune Sciences?

A short squeeze for Alpine Immune Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALPN, which in turn drives the price of the stock up even further.

How often is Alpine Immune Sciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALPN, twice per month. The most recent reporting period available is April, 30 2024.




This page (NASDAQ:ALPN) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners